Carlsmed, Inc.
CARL
$13.74
$0.141.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 98.70% | 100.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 98.70% | 100.33% | |||
| Cost of Revenue | 111.59% | 79.54% | |||
| Gross Profit | 94.41% | 108.41% | |||
| SG&A Expenses | 62.88% | 77.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 49.88% | 52.74% | |||
| Operating Income | -2.90% | -7.32% | |||
| Income Before Tax | -7.79% | -5.18% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.79% | -5.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.79% | -5.18% | |||
| EBIT | -2.90% | -7.32% | |||
| EBITDA | -2.50% | -7.37% | |||
| EPS Basic | 4.81% | -7.73% | |||
| Normalized Basic EPS | 4.80% | 2.23% | |||
| EPS Diluted | 4.81% | -7.73% | |||
| Normalized Diluted EPS | 4.80% | 2.23% | |||
| Average Basic Shares Outstanding | 13.24% | 7.58% | |||
| Average Diluted Shares Outstanding | 13.24% | 7.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||